Last10K.com

Acm Research, Inc. (ACMR) SEC Filing 10-Q Quarterly Report for the period ending Wednesday, June 30, 2021

Acm Research, Inc.

CIK: 1680062 Ticker: ACMR

Exhibit 99.01


ACM Research Reports First Quarter 2021 Results

FREMONT, California, May 6, 2021 (Globe Newswire) – ACM Research, Inc. (“ACM” or the “Company”) (NASDAQ:ACMR), a leading supplier of wafer cleaning technologies for advanced semiconductor devices, today reported financial results for its first fiscal quarter ended March 31, 2021.

ACM’s President and Chief Executive Officer Dr. David Wang commented, “We are off to a great start for 2021, with incremental contribution from new products and new customers, and solid execution by our manufacturing team.  For the first quarter, we grew revenue by 80% year-over-year, achieved record shipments of $74 million, and expanded production capacity with the addition of a second building at our factory in the Chuansha area of Pudong.  We continue to execute on our mission to become a major global player in the semiconductor equipment industry.”

Dr. Wang continued, “We are optimistic about our operating plans and business outlook for 2021.  We continue to anticipate solid growth from our flagship cleaning products, with meaningful contributions from our semi-critical cleaning and electrochemical plating (ECP) products.  We have made significant progress in North America, including hiring a seasoned team of industry veterans with decades of experience with major semiconductor manufacturers.  Although timing is still uncertain for the STAR Market IPO of our subsidiary ACM Research (Shanghai), Inc., we are confident that the IPO will be completed successfully.”

   
Three Months Ended March 31,
 
   
GAAP
   
Non-GAAP(1)
 
   
2021
   
2020
   
2021
   
2020
 
   
(dollars in thousands, except per share data)
 
Revenue
 
$
43,732
   
$
24,348
   
$
43,732
   
$
24,348
 
Gross margin
   
41.3
%
   
42.0
%
   
41.4
%
   
42.2
%
Income from operations
 
$
3,450
   
$
1,218
   
$
4,660
   
$
1,907
 
Net income attributable to ACM Research, Inc.
 
$
5,470
   
$
1,705
   
$
7,727
   
$
2,394
 
Basic EPS
 
$
0.29
   
$
0.09
   
$
0.41
   
$
0.13
 
Diluted EPS
 
$
0.25
   
$
0.08
   
$
0.35
   
$
0.11
 

(1)
Reconciliations to U.S. generally accepted accounting principles (“GAAP”) financial measures from non-GAAP financial measures are presented below under “Reconciliation of GAAP to Non-GAAP Financial Measures.” Non-GAAP financial measures exclude stock-based compensation and, with respect to net income (loss) attributable to ACM Research, Inc. and basic and diluted EPS, also exclude unrealized gain on trading securities.


Outlook

For fiscal year 2021, the Company continues to expect revenue to be in the range of $205 million to $230 million. This expectation assumes, among other factors, improvement with respect to the global COVID-19 pandemic and stability in US-China trade policy. The range of ACM’s 2021 outlook reflects, among other things, variances in spending scenarios for the production ramps of key customers, the trajectory of the DRAM recovery, and the timing of acceptances for first tools under evaluation in the field.

Operating Highlights and Recent Developments

Shipments. Total shipments in the first quarter of 2021 were $74 million, versus $12 million in the first quarter of 2020 and $67 million in the fourth quarter of 2020. Total shipments include deliveries for revenue in the quarter and deliveries of first tool systems awaiting customer acceptance for potential revenue in future quarters.

Scaling Production Capacity.  During the first quarter of 2021, ACM Shanghai leased an additional building immediately adjacent to its factory in the Chuansha area of Shanghai’s Pudong district.  The second building increases available floor space for production by 100,000 square feet, bringing the total available floor space in Chuansha to 200,000 square feet.

Broadened Ultra Fn Furnace Portfolio. During the first quarter of 2021, the Company broadened its Ultra Fn furnace dry processing tool portfolio with additional semiconductor manufacturing processes, including un-doped poly and doped poly low-pressure chemical vapor deposition (LPCVD). The new capabilities build on the configurable system’s previously announced oxide, silicon nitride (SiN) LPCVD, and alloy annealing process capabilities. ACM has delivered multiple tools supporting these new applications and expects to deliver additional units in the coming quarters.

Update on Engagement with Major First Tier Customers.  With resources added to its sales team, ACM is building a sales pipeline via ongoing engagement and technology discussions with U.S. and Taiwan-based prospects.  The Company believes it can secure initial orders from one or more new major first tier customers in 2021.

Update on ACM Shanghai IPO Activities. ACM Shanghai's application for an initial public offering of its shares on the STAR Market was approved by the Listing Committee of the Shanghai Stock Exchange Commission (the “SSEC”) on September 30, 2020.  Subsequently a short-seller report issued on October 8, 2020, followed by a class-action lawsuit on December 21, 2020 that cited the short-seller report, resulted in additional inquiries by the SSEC.  In response to those inquiries, ACM completed and submitted to the SSEC a second Verification Report in late March 2021.  Completion of the IPO is now dependent upon, among other factors, a successful review by the SSEC and registration by the China Securities Regulatory Commission.

Financial Summary

The following figures refer to the first quarter of 2021and comparisons are with the first quarter of 2020, unless otherwise noted.

Revenue was $43.7 million, up 79.6%, reflecting an increase in revenue from single wafer wet cleaning tools, advanced packaging and other back-end processing equipment.

Gross margin was 41.3%, compared to 42.0% in the first quarter of 2020.  Gross margin was within the range of 40% to 45% set forth in the Company’s long-term business model. The Company expects gross margin to vary from period to period due to a variety of factors, such as sales volume and product mix.

- 2 -

Operating expenses were $14.6 million, an increase of 62.0%.  Non-GAAP operating expenses, which exclude the effects of stock-based compensation, were $13.5 million, up 60.8%.  Non‑GAAP operating expenses as a percent of revenue decreased to 30.8%, compared to 34.4% in the first quarter of 2020.

Operating income of $3.5 million reflected an increase of 183% due to the increased revenue and operating leverage. Non-GAAP operating income of $4.7 million reflected an increase of 144%.

Unrealized loss on trading securities was $1.0 million in the first quarter of 2021. The loss reflects the change in market value of ACM Shanghai’s indirect investment in STAR Market IPO shares of Semiconductor Manufacturing International Corporation (“SMIC”), which began trading in mid-July 2020. The value was marked-to-market at quarter-end and is excluded from non-GAAP results.

Net income attributable to ACM Research, Inc. was $5.5 million, compared to $1.7 million in the first quarter of 2020.  Non-GAAP net income attributable to ACM Research, Inc. in the first quarter of 2021, excluding the effect of stock-based compensation and unrealized loss on trading securities, was $7.7 million as compared to $2.4 million in the first quarter of 2020.  Tax-related items (compared to a normalized tax rate), and the effects of foreign-exchange fluctuations on operating results provided net benefits of $3.8 million and $0.6 million in the first quarters of 2021 and 2020, respectively.

Net income per diluted share attributable to ACM Research, Inc. was $0.25, compared to $0.08 in the first quarter of 2020. Non-GAAP net income per diluted share, which excludes the effect of stock-based compensation and unrealized loss on trading securities, was $0.35 in the first quarter of 2021, compared to $0.11 in the first quarter of 2020. Tax items and effects of foreign-exchange fluctuations on operating results provided net benefits per share of $0.17 and $0.03 in the first quarters of 2021 and 2020, respectively.

- 3 -

Cash and equivalents at quarter-end were $78.8 million, versus $71.8 million at the end of the fourth quarter of 2020 and $52.3 million at the end of the first quarter of 2020.  The quarter-on-quarter increase was primarily due to positive cash flow from operations during the quarter.

Conference Call Details

A conference call to discuss results will be held on Friday, May 7, 2021, at 8:00 a.m. Eastern Time (8:00 p.m. China Time).  Dial-in details for the call are as follows.  Please reference conference ID 7084698.

 
Phone Number
Toll-Free Number
United States
+1 (661) 567-1217
+1 (833) 562-0137
Hong Kong
+852 5819 4851
+852 8009 66253
Mainland China
+86 8008700169
 
 
+86 4006828609
 

A recording of the webcast will be available on the investor page of the ACM website at www.acmrcsh.com for one week following the call.

Use of Non-GAAP Financial Measures

ACM presents non-GAAP gross margin, operating expenses, operating income, net income attributable to ACM Research, Inc., and basic and diluted earnings per share as supplemental measures to GAAP financial measures regarding ACM’s operational performance. These supplemental measures exclude the impact of stock-based compensation, which ACM does not believe is indicative of its core operating results. In addition, non-GAAP net income attributable to ACM Research, Inc. and basic and diluted EPS exclude non-cash change in fair value of financial assets and liabilities, which ACM also believes is not indicative of its core operating results. A reconciliation of each non-GAAP financial measure to the most directly comparable GAAP financial measure is provided below under “Reconciliation of Non-GAAP to GAAP Financial Measures.”

ACM believes these non-GAAP financial measures are useful to investors in assessing its operating performance. ACM uses these financial measures internally to evaluate its operating performance and for planning and forecasting of future periods. Financial analysts may focus on and publish both historical results and future projections based on the non-GAAP financial measures. ACM also believes it is in the best interests of investors for ACM to provide this non-GAAP information.

While ACM believes these non-GAAP financial measures provide useful supplemental information to investors, there are limitations associated with the use of these non-GAAP financial measures. These non-GAAP financial measures may not be reported by competitors, and they may not be directly comparable to similarly titled measures of other companies due to differences in calculation methodologies. The non-GAAP financial measures are not an alternative to GAAP information and are not meant to be considered in isolation or as a substitute for comparable GAAP financial measures. They should be used only as a supplement to GAAP information and should be considered only in conjunction with ACM’s consolidated financial statements prepared in accordance with GAAP.

- 4 -

Forward-Looking Statements

Certain statements contained in the third paragraph of this press release, under the heading “Outlook” above, and in the fourth bullet under “Operating Highlights and Recent Developments” above are not historical facts and may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements regarding the intent, belief and current expectations with respect to: the demand for ACM’s tools, including specifically in fiscal year 2021; the expansion in 2021 of ACM’s product offering, production capacity and base of major customers; the timing and ability of ACM to secure orders from new customers; and ACM’s plans for completion of the STAR Market initial public offering of shares of ACM Shanghai, which are expectations only, reflect management's current views, are based on certain assumptions, and involve risks and uncertainties. Actual results, events, or performance may differ materially from the above forward-looking statements due to a number of important factors, and will be dependent upon a variety of factors, including, but not limited to, the following, any of which could be exacerbated even further by the continuing COVID-19 outbreak in China and globally; anticipated customer orders or identified market opportunities may not grow or develop as anticipated; customer orders already received may be postponed or canceled; ACM may be unable to obtain the qualification and acceptance of its delivered tools when anticipated or at all, which would delay or preclude ACM’s recognition of revenue from the sale of those tools; suppliers may not be able to meet ACM’s demands on a timely basis; ACM’s technologies and tools may not gain market acceptance; ACM may be unable to compete effectively by, among other things, enhancing its existing tools, adding additional production capacity and engaging additional major customers; volatile global economic, market, industry and other conditions could result in sharply lower demand for products containing semiconductors and for the Company's products and in disruption of capital and credit markets; trade regulations, currency fluctuations, political instability and war may materially adversely affect ACM due to its substantial non-U.S. customer and supplier base and its substantial non-U.S. manufacturing operations. The completion and timing of ACM Shanghai’s obtaining of remaining regulatory approval for the STAR Market IPO and listing of its shares are subject to numerous risks, such as the receipt of all necessary Chinese governmental approvals, that are outside ACM’s control. ACM cannot guarantee any future results, levels of activity, performance or achievements.  ACM undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in its expectations regarding these forward-looking statements or the occurrence of unanticipated events.

About ACM Research, Inc.

ACM develops, manufactures, and sells semiconductor process equipment for single-wafer or batch wet cleaning, electroplating, stress-free polishing and thermal processes that are critical to advanced semiconductor device manufacturing, as well as wafer-level packaging. The Company is committed to delivering customized, high performance, cost-effective process solutions that semiconductor manufacturers can use in numerous manufacturing steps to improve productivity and product yield.

© ACM Research, Inc. ULTRA Furnace and the ACM Research logo are trademarks of ACM Research, Inc. For convenience, these trademarks appear in this press release without ™ symbols, but that practice does not mean that ACM will not assert, to the fullest extent under applicable law, its rights to the trademarks.

- 5 -

For investor and media inquiries, please contact:

In the United States:
The Blueshirt Group
 
Ralph Fong
 
+1 (415) 489-2195
 
ralph@blueshirtgroup.com
   
In China:
The Blueshirt Group Asia
 
Gary Dvorchak, CFA
 
+86 (138) 1079-1480
 
gary@blueshirtgroup.com

- 6 -

ACM RESEARCH, INC.
Condensed Consolidated Balance Sheets

   
March 31, 2021
   
December 31, 2020
 
   
(Unaudited)
 
   
(In thousands, except share and per share data)
 
Assets
           
Current assets:
           
Cash and cash equivalents
 
$
78,796
   
$
71,766
 
Trading securities
   
27,003
     
28,239
 
Accounts receivable, less allowance for doubtful accounts of $0 as of March 31, 2021 and December 31, 2020
   
60,394
     
56,441
 
Other receivables
   
11,216
     
9,679
 
Inventories
   
103,226
     
88,639
 
Prepaid expenses
   
5,917
     
5,892
 
Total current assets
   
286,552
     
260,656
 
Property, plant and equipment, net
   
8,772
     
8,192
 
Land use right, net
   
9,529
     
9,646
 
Operating lease right-of-use assets, net
   
5,349
     
4,297
 
Intangible assets, net
   
602
     
554
 
Deferred tax assets
   
13,908
     
11,076
 
Long-term investments
   
6,632
     
6,340
 
Other long-term assets
   
40,475
     
40,496
 
Total assets
   
371,819
     
341,257
 
Liabilities and Stockholders’ Equity
               
Current liabilities:
               
Short-term borrowings
   
23,490
     
26,147
 
Current portion of long-term borrowings
   
1,598
     
1,591
 
Accounts payable
   
44,721
     
35,603
 
Advances from customers
   
32,668
     
17,888
 
Deferred revenue
   
1,315
     
1,343
 
Income taxes payable
   
105
     
31
 
FIN-48 payable
   
82
     
83
 
Other payables and accrued expenses
   
21,885
     
18,805
 
Current portion of operating lease liability
   
2,171
     
1,417
 
Total current liabilities
   
128,035
     
102,908
 
Long-term borrowings
   
17,444
     
17,979
 
Long-term operating lease liability
   
3,178
     
2,880
 
Deferred tax liability
   
1,276
     
1,286
 
Other long-term liabilities
   
6,639
     
8,034
 
Total liabilities
   
156,572
     
133,087
 
Commitments and contingencies
               
Stockholders’ equity:
               
Common stock – Class A, par value $0.0001: 50,000,000 shares authorized as of March 31, 2021 and December 31, 2020; 17,239,967 shares issued and outstanding as of March 31, 2021 and 16,896,693 shares issued and outstanding as of December 31, 2020
   
2
     
2
 
Common stock–Class B, par value $0.0001: 2,409,738 shares authorized as of March 31, 2021 and December 31, 2020; 1,769,272 shares issued and outstanding as of March 31, 2021 and 1,802,606 shares issued and outstanding as of December 31, 2020
   
-
     
-
 
Additional paid in capital
   
104,591
     
102,004
 
Accumulated surplus
   
39,757
     
34,287
 
Accumulated other comprehensive income
   
3,961
     
4,857
 
Total ACM Research, Inc. stockholders’ equity
   
148,311
     
141,150
 
Non-controlling interests
   
66,936
     
67,020
 
Total stockholders’ equity
   
215,247
     
208,170
 
Total liabilities and stockholders’ equity
 
$
371,819
   
$
341,257
 

- 7 -

ACM RESEARCH, INC.
Condensed Consolidated Statements of Operations and Comprehensive Income

   
Three Months Ended March 31,
 
   
2021
   
2020
 
   
(Unaudited)
 
   
( In thousands, except share and per share data)
 
Revenue
 
$
43,732
   
$
24,348
 
Cost of revenue
   
25,687
     
14,120
 
Gross profit
   
18,045
     
10,228
 
Operating expenses:
               
Sales and marketing
   
5,308
     
3,005
 
Research and development
   
5,504
     
3,677
 
General and administrative
   
3,783
     
2,328
 
Total operating expenses, net
   
14,595
     
9,010
 
Income from operations
   
3,450
     
1,218
 
Interest income
   
49
     
335
 
Interest expense
   
(189
)
   
(111
)
Unrealized loss on trading securities
   
(1,047
)
   
-
 
Other income, net
   
469
     
677
 
Equity income in net income of affiliates
   
320
     
148
 
Income before income taxes
   
3,052
     
2,267
 
Income tax benefit (expense)
   
2,770
     
(304
)
Net income
   
5,822
     
1,963
 
Less: Net income attributable to non-controlling interests and redeemable non-controlling interests
   
352
     
258
 
Net income attributable to ACM Research, Inc.
 
$
5,470
   
$
1,705
 
Comprehensive income:
               
Net income
   
5,822
     
1,963
 
Foreign currency translation adjustment
   
(1,332
)
   
(1,900
)
Comprehensive Income
   
4,490
     
63
 
Less: Comprehensive income attributable to non-controlling interests and redeemable non-controlling interests
   
(83
)
   
(694
)
Comprehensive income attributable to ACM Research, Inc.
 
$
4,573
   
$
757
 
                 
Net income attributable to ACM Research, Inc. per common share:
               
Basic
 
$
0.29
   
$
0.09
 
Diluted
 
$
0.25
   
$
0.08
 
                 
Weighted average common shares outstanding used in computing per share amounts:
               
Basic
   
18,786,870
     
18,120,363
 
Diluted
   
21,868,280
     
21,066,636
 

- 8 -

ACM RESEARCH, INC.
Total Revenue by Product Category, by Equipment Type and by Region

   
Three Months Ended March 31,
 
Total Revenue By Product Category
 
2021
   
2020
 
Single Wafer Cleaning Tools (SAPS, TEBO, Tahoe) and Semi-Critical Cleaning Equipment
 
$
32,413
   
$
22,784
 
ECP (front-end and packaging), Furnace and Other Technologies
   
5,550
     
-
 
Advanced Packaging (excluding ECP), and Services & Spare Parts
   
5,769
     
1,564
 
   
$
43,732
   
$
24,348
 

   
Three Months Ended March 31,
 
Total Revenue By Equipment Type (Front-end / Back-end)
   
2021
     
2020
 
Wet Cleaning and Other Front-end Processing Tools
 
$
31,900
   
$
22,784
 
Advanced Packaging, Other Back-end Processing Tools, and Services & Spare Parts
   
11,832
     
1,564
 
   
$
43,732
   
$
24,348
 

   
Three Months Ended March 31,
 
Total Revenue By Region
   
2021
     
2020
 
Mainland China
 
$
43,696
   
$
24,289
 
Other Regions
   
36
     
59
 
   
$
43,732
   
$
24,348
 

- 9 -

ACM RESEARCH, INC.
Reconciliation of GAAP to Non-GAAP Financial Measures

As described under “Use of Non-GAAP Financial Measures” above, ACM presents non-GAAP gross margin, operating expenses, operating income, net income attributable to ACM Research, Inc., and basic and diluted earnings per share as supplemental measures to GAAP financial measures, each of which excludes stock-based compensation (“SBC”) from the equivalent GAAP financial line items. In addition, non-GAAP net income (loss) attributable to ACM Research, Inc., and basic and diluted earnings per share exclude non-cash change in fair value of financial liabilities and unrealized gain on trading securities. The following table reconciles gross margin, operating expenses, operating income, net income attributable to ACM Research, Inc., and basic and diluted earnings per share to the related non-GAAP financial measures:


   
Three Months Ended March 31,
 
   
2021
   
2020
 
   
Actual
   
SBC
   
Other non-operating adjustments
   
Adjusted
   
Actual
   
SBC
   
Adjusted
 
 
(GAAP)
   
(Non-GAAP)
   
(GAAP)
   
(Non-GAAP)
 
   
(In thousands)
 
Revenue
 
$
43,732
   
$
-
   
$
-
   
$
43,732
   
$
24,348
   
$
-
   
$
24,348
 
Cost of revenue
   
(25,687
)
   
(71
)
   
-
     
(25,616
)
   
(14,120
)
   
(45
)
   
(14,075
)
Gross profit
   
18,045
     
(71
)
   
-
     
18,116
     
10,228
     
(45
)
   
10,273
 
Gross margin %
   
41.3
%
   
0.2
%
           
41.4
%
   
42.0
%
   
0.2
%
   
42.2
%
Operating expenses:
                                                       
Sales and marketing
   
(5,308
)
   
(505
)
   
-
     
(4,803
)
   
(3,005
)
   
(94
)
   
(2,911
)
Research and development
   
(5,504
)
   
(229
)
   
-
     
(5,275
)
   
(3,677
)
   
(187
)
   
(3,490
)
General and administrative
   
(3,783
)
   
(405
)
   
-
     
(3,378
)
   
(2,328
)
   
(363
)
   
(1,965
)
Income from operations
 
$
3,450
   
$
(1,210
)
 
$
-
   
$
4,660
   
$
1,218
   
$
(689
)
 
$
1,907
 
Operating margin %
   
7.9
%
   
2.8
%
           
10.7
%
   
5.0
%
   
2.8
%
   
7.8
%
Unrealized loss on trading securities
   
(1,047
)
   
-
     
(1,047
)
   
-
     
-
     
-
     
-
 
Net income attributable to ACM Research, Inc.
 
$
5,470
   
$
(1,210
)
 
$
(1,047
)
 
$
7,727
   
$
1,705
   
$
(689
)
 
$
2,394
 
Basic EPS
 
$
0.29
                   
$
0.41
   
$
0.09
           
$
0.13
 
Diluted EPS
 
$
0.25
                   
$
0.35
   
$
0.08
           
$
0.11
 


- 10 -


The following information was filed by Acm Research, Inc. (ACMR) on Thursday, May 6, 2021 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-Q Quarterly Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one quarter to another to evaluate Acm Research, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Acm Research, Inc..

Continue

Assess how Acm Research, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Acm Research, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2021 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

Tools

Rating

Learn More
Bullish Bearish Neutral
Filter by Sentiment:
All
Positive
Negative
Filter by Category:
All
Financial
Revenue
Other
Filter by Subcategory:
All
Cash Flow
Earnings
Income
Expense
Shares
Product
Geography
Other
Inside Acm Research, Inc.'s 10-Q Quarterly Report:

Financial Statements, Disclosures and Schedules

Inside this 10-Q Quarterly Report

Document And Entity Information
Condensed Consolidated Balance Sheets
Condensed Consolidated Balance Sheets (Parenthetical)
Condensed Consolidated Statements Of Cash Flows
Condensed Consolidated Statements Of Changes In Stockholders' Equity
Condensed Consolidated Statements Of Operations And Comprehensive Income
Accounts Receivable
Accounts Receivable (Details)
Accounts Receivable (Tables)
Commitments And Contingencies
Commitments And Contingencies (Details)
Common Stock
Common Stock (Details)
Description Of Business
Description Of Business (Details)
Description Of Business (Tables)
Financial Liability Carried At Fair Value
Financial Liability Carried At Fair Value (Details)
Financial Liability Carried At Fair Value (Tables)
Income Taxes
Income Taxes (Details)
Income Taxes (Tables)
Inventories
Inventories (Details)
Inventories (Tables)
Land Use Right, Net
Land Use Right, Net (Details)
Land Use Right, Net (Tables)
Leases
Leases (Details)
Leases (Tables)
Long Term Investment
Long Term Investment (Details)
Long Term Investment (Tables)
Long-Term Borrowings
Long-Term Borrowings (Details)
Long-Term Borrowings (Tables)
Other Long-Term Assets
Other Long-Term Assets (Details)
Other Long-Term Assets (Tables)
Other Long-Term Liabilities
Other Long-Term Liabilities (Details)
Other Long-Term Liabilities (Tables)
Other Payable And Accrued Expenses
Other Payable And Accrued Expenses (Details)
Other Payable And Accrued Expenses (Tables)
Property, Plant And Equipment, Net
Property, Plant And Equipment, Net (Details)
Property, Plant And Equipment, Net (Tables)
Redeemable Non-Controlling Interests
Redeemable Non-Controlling Interests (Details)
Redeemable Non-Controlling Interests (Tables)
Related Party Balances And Transactions
Related Party Balances And Transactions (Details)
Related Party Balances And Transactions (Tables)
Revenue From Contracts With Customers
Revenue From Contracts With Customers (Details)
Revenue From Contracts With Customers (Tables)
Short-Term Borrowings
Short-Term Borrowings (Details)
Short-Term Borrowings (Tables)
Stock-Based Compensation
Stock-Based Compensation (Tables)
Stock-Based Compensation, Assumptions Used To Determine Fair Value Of Share Options Granted (Details)
Stock-Based Compensation, Share Option Activities (Details)
Stock-Based Compensation, Stock-Based Compensation Expense (Details)
Subsequent Event
Subsequent Event (Details)
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (Policies)
Summary Of Significant Accounting Policies (Tables)
Summary Of Significant Accounting Policies, Basic And Diluted Net Income Per Common Share (Details)
Summary Of Significant Accounting Policies, Concentration Of Credit Risk (Details)
Summary Of Significant Accounting Policies, Covid-19 Assessment (Details)
Trading Securities
Trading Securities (Details)
Trading Securities (Tables)

Material Contracts, Statements, Certifications & more

Acm Research, Inc. provided additional information to their SEC Filing as exhibits

Ticker: ACMR
CIK: 1680062
Form Type: 10-Q Quarterly Report
Accession Number: 0001140361-21-027398
Submitted to the SEC: Fri Aug 06 2021 5:20:52 PM EST
Accepted by the SEC: Fri Aug 06 2021
Period: Wednesday, June 30, 2021
Industry: Special Industry Machinery

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/acmr/0001140361-21-027398.htm